Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:DPLO

Diplomat Pharmacy (DPLO) Stock Price, News & Analysis

Diplomat Pharmacy logo

About Diplomat Pharmacy Stock (NYSE:DPLO)

Advanced Chart

Key Stats

Today's Range
$4.00
$4.01
50-Day Range
$4.00
$4.00
52-Week Range
$2.43
$14.46
Volume
744,968 shs
Average Volume
545,194 shs
Market Capitalization
$304 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DPLO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Diplomat Pharmacy and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DPLO Stock News Headlines

Missed the Last 10,000% Surge? Here’s Your Next Chance
Axcelis Technologies went from $2.50 to $180—a staggering 7,100% return. These are the kinds of small-cap breakouts Fierce Analyst aims to catch before they go mainstream. Our research team uses data and trend analysis to uncover high-potential stocks early. And now, you can get free alerts on the next set of breakout candidates—before the crowd rushes in.tc pixel
Netflix's Hostage feels like The Diplomat lite
See More Headlines

DPLO Stock Analysis - Frequently Asked Questions

Diplomat Pharmacy Inc (NYSE:DPLO) announced its quarterly earnings data on Tuesday, November, 12th. The company reported ($2.35) EPS for the quarter, missing analysts' consensus estimates of ($0.20) by $2.15. The firm's quarterly revenue was down 5.3% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Diplomat Pharmacy investors own include Bausch Health Cos (BHC), Gilead Sciences (GILD), Bristol Myers Squibb (BMY), Cara Therapeutics (CARA), Cannabis Sativa (CBDS), CVS Health (CVS) and Jazz Pharmaceuticals (JAZZ).

Company Calendar

Last Earnings
11/12/2019
Today
8/29/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Drug Stores & Proprietary Stores
Sub-Industry
N/A
Current Symbol
NYSE:DPLO
CIK
1610092
Fax
N/A
Employees
2,335
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.20
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$302.27 million
Net Margins
-12.47%
Pretax Margin
N/A
Return on Equity
-12.15%
Return on Assets
-3.05%

Debt

Debt-to-Equity Ratio
0.18
Current Ratio
0.55
Quick Ratio
0.36

Sales & Book Value

Annual Sales
$5.49 billion
Price / Sales
0.06
Cash Flow
$4.60 per share
Price / Cash Flow
0.87
Book Value
$6.24 per share
Price / Book
0.64

Miscellaneous

Outstanding Shares
76,000,000
Free Float
N/A
Market Cap
$304 million
Optionable
Optionable
Beta
0.82
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NYSE:DPLO) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners